Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Redd

Showing results (121-130 of 175) with videos related to

Pageof 18
Sort By:
Medrxiv : the Preprint Server for Health Sciences|February 3, 2021
Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titersChristopher D Heaney, Nora Pisanic, Pranay R Randad, et al.
Eclinicalmedicine|November 12, 2019
Targeting the HIV Epidemic in South Africa: The Need for Testing and Linkage to Care in Emergency DepartmentsBhakti Hansoti, George Mwinnyaa, Elizabeth Hahn, et al.
Biorxiv : the Preprint Server for Biology|October 14, 2020
CD8+ T cell responses in convalescent COVID-19 individuals target epitopes from the entire SARS-CoV-2 proteome and show kinetics of early differentiationHassen Kared, Andrew D Redd, Evan M Bloch, et al.
The Journal of Infectious Diseases|September 22, 2012
Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissionsAndrew D Redd, Aleisha N Collinson-Streng, Nikolaos Chatziandreou, et al.
The Journal of Clinical Investigation|January 11, 2021
SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individualsHassen Kared, Andrew D Redd, Evan M Bloch, et al.
Medrxiv : the Preprint Server for Health Sciences|October 21, 2021
Differentiation of SARS-CoV-2 naturally infected and vaccinated individuals in an inner-city emergency departmentEvan J Beck, Yu-Hsiang Hsieh, Reinaldo E Fernandez, et al.
BMC Immunology|February 17, 2022
Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2Harini Natarajan, Shiwei Xu, Andrew R Crowley, et al.
Medrxiv : the Preprint Server for Health Sciences|August 17, 2021
Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2Harini Natarajan, Shiwei Xu, Andrew R Crowley, et al.
PLOS Global Public Health|June 12, 2025
Correction: SARS-CoV-2 seroepidemiology in Cape Town, South Africa, and implications for future outbreaks in low-income communitiesHannah Hussey, Helena Vreede, Mary-Ann Davies, et al.
Nature Communications|July 2, 2024
HIV-1 subtype A1, D, and recombinant proviral genome landscapes during long-term suppressive therapyGuinevere Q Lee, Pragya Khadka, Sarah N Gowanlock, et al.
Pageof 18

Showing results (121-130 of 175) with videos related to

Sort By:
Pageof 18
Medrxiv : the Preprint Server for Health Sciences|February 3, 2021
Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titersChristopher D Heaney, Nora Pisanic, Pranay R Randad, et al.
Eclinicalmedicine|November 12, 2019
Targeting the HIV Epidemic in South Africa: The Need for Testing and Linkage to Care in Emergency DepartmentsBhakti Hansoti, George Mwinnyaa, Elizabeth Hahn, et al.
Biorxiv : the Preprint Server for Biology|October 14, 2020
CD8+ T cell responses in convalescent COVID-19 individuals target epitopes from the entire SARS-CoV-2 proteome and show kinetics of early differentiationHassen Kared, Andrew D Redd, Evan M Bloch, et al.
The Journal of Infectious Diseases|September 22, 2012
Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissionsAndrew D Redd, Aleisha N Collinson-Streng, Nikolaos Chatziandreou, et al.
The Journal of Clinical Investigation|January 11, 2021
SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individualsHassen Kared, Andrew D Redd, Evan M Bloch, et al.
Medrxiv : the Preprint Server for Health Sciences|October 21, 2021
Differentiation of SARS-CoV-2 naturally infected and vaccinated individuals in an inner-city emergency departmentEvan J Beck, Yu-Hsiang Hsieh, Reinaldo E Fernandez, et al.
BMC Immunology|February 17, 2022
Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2Harini Natarajan, Shiwei Xu, Andrew R Crowley, et al.
Medrxiv : the Preprint Server for Health Sciences|August 17, 2021
Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2Harini Natarajan, Shiwei Xu, Andrew R Crowley, et al.
PLOS Global Public Health|June 12, 2025
Correction: SARS-CoV-2 seroepidemiology in Cape Town, South Africa, and implications for future outbreaks in low-income communitiesHannah Hussey, Helena Vreede, Mary-Ann Davies, et al.
Nature Communications|July 2, 2024
HIV-1 subtype A1, D, and recombinant proviral genome landscapes during long-term suppressive therapyGuinevere Q Lee, Pragya Khadka, Sarah N Gowanlock, et al.
Pageof 18